Successful Use of Adalimumab in Treating Granuloma Faciale Resistant to Traditional Therapies.

Australasian Journal of DermatologyEarly View LETTER Successful use of adalimumab in treating granuloma faciale resistant to traditional therapies Martina Mussi MD, Martina Mussi MD orcid.org/0000-0003-0955-6112 Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, ItalySearch for more papers by this authorCorrado Zengarini MD, Corrado Zengarini MD Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, ItalySearch for more papers by this authorFilippo Viviani MD, Filippo Viviani MD Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, ItalySearch for more papers by this authorLidia Sacchelli MD, Lidia Sacchelli MD orcid.org/0000-0003-4388-4523 Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalySearch for more papers by this authorAlessandro Pileri MD, PhD, Corresponding Author Alessandro Pileri MD, PhD [email protected] Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, Italy Correspondence Alessandro Pileri, Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Via Massarenti, 1 - 40138 Bologna, Italy. Email: [email protected]Search for more papers by this authorFederico Bardazzi MD, Federico Bardazzi MD Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalySearch for more papers by this author Martina Mussi MD, Martina Mussi MD orcid.org/0000-0003-0955-6112 Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, ItalySearch for more papers by this authorCorrado Zengarini MD, Corrado Zengarini MD Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, ItalySearch for more papers by this authorFilippo Viviani MD, Filippo Viviani MD Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, ItalySearch for more papers by this authorLidia Sacchelli MD, Lidia Sacchelli MD orcid.org/0000-0003-4388-4523 Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalySearch for more papers by this authorAlessandro Pileri MD, PhD, Corresponding Author Alessandro Pileri MD, PhD [email protected] Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Bologna, Italy Correspondence Alessandro Pileri, Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Via Massarenti, 1 - 40138 Bologna, Italy. Email: [email protected]Search for more papers by this authorFederico Bardazzi MD, Federico Bardazzi MD Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalySearch for more papers by this author First published: 14 April 2024 https://doi.org/10.1111/ajd.14260Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Sand FL, Thomsen SF. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther. 2015; 28(3): 158–165. https://doi.org/10.1111/dth.12222 10.1111/dth.12222 PubMedWeb of Science®Google Scholar 2Alwawi EA, Mehlis SL, Gordon KB. Treating psoriasis with adalimumab. Ther Clin Risk Manag. 2008; 4(2): 345–351. https://doi.org/10.2147/tcrm.s1265 10.2147/tcrm.s1265 CASPubMedGoogle Scholar 3Frantz R, Chukwuma O, Sokumbi O, Satcher K, Kallis P, Vincek V, et al. Identifying histopathologic features of erythema elevatum diutinum and granuloma faciale. J Cutan Pathol. 2022; 49(3): 323–326. https://doi.org/10.1111/cup.14191 10.1111/cup.14191 PubMedWeb of Science®Google Scholar 4Lindhaus C, Elsner P. Granuloma faciale treatment: a systematic review. Acta Derm Venereol. 2018; 98(1): 14–18. 10.2340/00015555-2784 CASPubMedWeb of Science®Google Scholar 5Rozenblat M, Ziv M. Systemic review of eosinophilic dermatoses patients treated with tnf-α inhibitors and ustekinumab. Harefuah. 2020; 159(1): 34–37. PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation